Preziosa, Paolo
Rocca, Maria A.
Nozzolillo, Agostino
Moiola, Lucia
Filippi, Massimo http://orcid.org/0000-0002-5485-0479
Article History
Received: 27 August 2020
Revised: 2 November 2020
Accepted: 8 November 2020
First Online: 20 November 2020
Compliance with ethical standards
:
: P. Preziosa received speakers honoraria from Biogen Idec, Novartis, Merck-Serono, and ExceMED. M.A. Rocca received speakers honoraria from Biogen Idec, Novartis, Genzyme, Teva, MS, R, Celgene, and Bayer, and receives research support from the MS Society of Canada and Fondazione Italiana Sclerosi Multipla. A. Nozzolillo has nothing to disclose. L. Moiola has received honoraria from Companies Biogen, Roche, TEVA, Sanofi, Serono, and Novartis. MF is Editor-in-Chief of the Journal of Neurology; received compensation for consulting services and/or speaking activities from Bayer, Biogen Idec, Merck-Serono, Novartis, Roche, Sanofi Genzyme, Takeda, and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA).
: This study has been approved by the local ethics committee and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: All patients provided consent to be anonymously included in this report.
: All authors have consented to publication.
: Not applicable.
Free to read: This content has been made available to all.